Carboplatin, Gemcitabine Hydrochloride, and Mifepristone in Treating Patients With Advanced Breast Cancer or Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
Conditions
- Male Breast Cancer
- Recurrent Breast Cancer
- Recurrent Fallopian Tube Cancer
- Recurrent Ovarian Epithelial Cancer
- Recurrent Primary Peritoneal Cavity Cancer
- Stage IIIB Breast Cancer
- Stage IIIC Breast Cancer
- Stage IV Breast Cancer
Interventions
- DRUG: mifepristone
- DRUG: carboplatin
- DRUG: gemcitabine hydrochloride
- OTHER: laboratory biomarker analysis
- OTHER: pharmacological study
Sponsor
University of Chicago
Collaborators